Skip to main content
Log in

Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Introduction

Early diagnosis and treatment of thyroid eye disease (TED) improves outcomes. Previous studies have highlighted delays in diagnosis and referral to specialist centres. The Amsterdam declaration (2009) aimed to halve the time from presentation to diagnosis and from diagnosis to referral to a specialist centre in five years. A recent study from the European group on Graves’ orbitopathy tertiary centres showed a trend for earlier referral of patients to the centres. It is unknown whether similar improvements are occurring in secondary care hospitals in the UK.

Aim

To study the trend in referral to a UK secondary care specialist TED clinic since the Amsterdam declaration.

Methods

We carried out a prospective audit of patients who attended the specialist TED clinic after the Amsterdam declaration (2010–2015). We compared their clinical characteristics, including duration of symptoms, disease activity and severity, with those of the patients (n = 114) from an earlier audit attending the clinic during 2004–2008.

Results

During 2010–2015, 126 patients with TED (97 females, median age 55 years, 39 current smokers) attended the clinic. The median time from onset of symptoms to being seen in the clinic was 5 months, reduced from 12 months in 2004–2008 (p < 0.001). As compared to the 2004–2008 cohort, significantly more patients in the current cohort presented with mild disease (72 vs. 52%, p = 0.002). Twenty-seven per cent patients had active TED (clinical activity score ≥3/7) compared to 18% in 2004–2008 (p = 0.1).

Conclusions

The trend in referral to secondary care specialist TED clinic is changing in line with the Amsterdam declaration aims.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Perros P, Neoh C, Dickinson J (2009) Thyroid eye disease. BMJ 338:b560

    Article  PubMed  Google Scholar 

  2. Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362(8):726–738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L (2013) Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed graves’ hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98(4):1443–1449

    Article  CAS  PubMed  Google Scholar 

  4. Estcourt S, Quinn AG, Vaidya B (2011) Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol 164(5):649–655

    Article  CAS  PubMed  Google Scholar 

  5. Ponto KA, Merkesdal S, Hommel G, Pitz S, Pfeiffer N, Kahaly GJ (2013) Public health relevance of Graves’ orbitopathy. J Clin Endocrinol Metab 98(1):145–152

    Article  CAS  PubMed  Google Scholar 

  6. Wiersinga WM (2016) Advances in treatment of active, moderate-to-severe Graves’ ophthalmopathy. Lancet Diabetes Endocrinol S2213–8587(16):30046–30048

    Google Scholar 

  7. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM (2008) European Group on Graves’ Orbitopathy (EUGOGO). Consensus statement of the European Group on Graves’ Orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273–285

    Article  CAS  PubMed  Google Scholar 

  8. Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B (2009) The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey. Eur J Endocrinol 161(3):483–487

    Article  CAS  PubMed  Google Scholar 

  9. Prummel MF, Bakker A, Wiersinga WM et al (2003) Multi-center study on the characteristics and treatment strategies of patients with Graves’ orbitopathy: the first European group on Graves’ orbitopathy experience. Eur J Endocrinol 148:491–495

    Article  CAS  PubMed  Google Scholar 

  10. Sasim IV, Berendschot TT, van Isterdael C, Mourtis MP (2008) Planning health care for patients with Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol 246:1315–1321

    Article  PubMed  PubMed Central  Google Scholar 

  11. The Amsterdam Declaration (2010) Graves’ orbitopathy: improving outcomes for thyroid eye disease—the Amsterdam declaration. Thyroid 20(3):351–352

    Article  Google Scholar 

  12. Perros P, Žarković M, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L, Boschi A, Bournaud C, Brix TH, Covelli D, Ćirić S, Daumerie C, Eckstein A, Fichter N, Führer D, Hegedüs L, Kahaly GJ, Konuk O, Lareida J, Lazarus J, Leo M, Mathiopoulou L, Menconi F, Morris D, Okosieme O, Orgiazzi J, Pitz S, Salvi M, Vardanian-Vartin C, Wiersinga W, Bernard M, Clarke L, Currò N, Dayan C, Dickinson J, Knežević M, Lane C, Marcocci C, Marinò M, Möller L, Nardi M, Neoh C, Pearce S, von Arx G, Törüner FB (2015) PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group on Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol 99(11):1531–1535

    Article  PubMed  Google Scholar 

  13. Benzimra JD, Quinn AG, Kersey T, McGrane D, Goss L, Vaidya B (2014) Management of patients in a combined thyroid eye clinic in secondary care. Int Ophthalmol 34(1):1–6

    Article  CAS  PubMed  Google Scholar 

  14. The European Group on Graves’ Orbitopathy (EUGOGO) (2016) (http://www.eugogo.eu/downloads.html). Accessed 26 Nov 2016

  15. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 47(1):9–14

    Article  CAS  Google Scholar 

  16. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves’ Orbitopathy (EUGOGO) (2016) The 2016 European thyroid association/European Group on Graves’ Orbitopathy guidelines for the management of Graves’ orbitopathy. Eur Thyroid J 5(1):9–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. The UK thyroid eye disease Amsterdam declaration implementation group (TEAMeD) (2016) (http://www.btf-thyroid.org/projects/teamed). Accessed 26 Nov 2016

  18. Perros P, Dayan CM, Dickinson AJ, Ezra D, Estcourt S, Foley P, Hickey J, Lazarus JH, MacEwen CJ, McLaren J, Rose GE, Uddin J, Vaidya B (2015) Management of patients with Graves’ orbitopathy: initial assessment, management outside specialised centres and referral pathways. Clin Med (Lond) 15(2):173–178

    Article  Google Scholar 

  19. Mitchell AL, Goss L, Mathiopoulou L, Morris M, Vaidya B, Dickinson AJ, Quinn A, Dayan C, McLaren J, Hickey JL, Lazarus JH, Rose GE, Foley P, MacEwen CJ, Perros P (2015) Diagnosis of Graves’ orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists. J Clin Endocrinol Metab 100(3):E458–E462

    Article  CAS  PubMed  Google Scholar 

  20. Mitchell AL, Zammitt N, Ajjan R, Vaidya B, Hickey J, Perros P, Dayan C (2016) Increasing awareness of Graves’ orbitopathy with “Early warning” cards—a TEAMeD multicentre quality improvement project. Endocr Abstr 44:P236

    Google Scholar 

  21. Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W, European Group on Graves’ Orbitopathy (2011) Selenium and the course of mild Graves’ orbitopathy. N Engl J Med 364(20):1920–1931

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annika S. Quinn.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Quinn, A.S., Dujardin, L.R., Knight, B. et al. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration. Int Ophthalmol 38, 301–306 (2018). https://doi.org/10.1007/s10792-017-0463-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-017-0463-0

Keywords

Navigation